Skip To Main Content
Yingxiang Lin on Muck Rack

Yingxiang Lin

As seen in: BMJ Open, ersnet.org
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingxiang

Contact Yingxiang, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Implementing acute exacerbations of COPD care bundles: evidence, effectiveness and future directions

|
By Jian Wang, Chenxi Shi, Yingxiang Lin
| ersnet.org
Introduction Chronic obstructive pulmonary disease (COPD) remains a major global health challenge. The World Health Organization estimated that COPD caused 3.5 million deaths in 2021, accounting for approximately 5% of all global deaths, with nearly 90% of premature COPD deaths occurring in low- and middle-income countries [1].
Open in Who Shared Issue with article?

Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol

|
By Lirong Liang, Lin Feng, Shuai Shao, Yingxiang Lin
| BMJ Open Verified
Methods Study design This is an investigator-initiated, multicentre, randomised, double-blind, parallel controlled, superiority trial in the respiratory departments or the respiratory and critical care medicine departments at 12 general hospitals in Beijing. The details of the participating hospitals are listed in online supplemental appendix 1. The study was prospectively registered with ClinicalTrials.gov on 10 August 2021.
Open in Who Shared Issue with article?
See all 2 articles